- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
WellPoint PBM business for sale
WellPoint decision to sell off its PBM business is seen by experts as good, strategic move for the health insurer.
WellPoint has put its pharmacy benefits management (PBM) business up for auction, which is likely to attract interest from CVS Caremark, Medco Health Solutions Inc. and Express Scripts Inc., among others.
Wellpoint’s decision to place their PBM up for auction is a good strategic move, believes Robert Taketomo, PharmD, MBA, president and CEO of Ventegra in La Jolla, Calif. “The PBM industry has been one of the most profitable industry segments and the stocks still trade at relatively high valuations. Loss of PBM functionality should not hurt Wellpoint if they still maintain control of the key pharmacy and medical decisions.”
According to Clive Riddle, president and founder of MCOL, a provider of business-to-business health management and managed care resources in Modesto, Calif., many large health plans have in-house PBMs, and “there is often intense pressure from the analyst and investor community to imitate such initiatives.” It is unlikely that WellPoint will be the only plan to go down this path in the near future".
The sale of WellPoint's PBM business, the fourth-largest in the United States, is said to be worth anywhere from less than $1 billion to five times that amount.
Extending the Capabilities of the EHR Through Automation
August 2nd 2023Welcome back to another episode of "Tuning In to the C-Suite," where Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of chatting with Cindy Gaines, chief clinical transformation officer at Lumeon.
Listen
Automate Your Practice's Workflows with These 5 Tools
October 4th 2023To maintain patient satisfaction and regulatory compliance and reduce potential clerical errors while maintaining high productivity, you can ease your staff’s burdens by automating your practice’s workflows and empower your staff to do more in less time.
Read More
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More
